← Leaderboards
George Kay
Revbio, Inc.
$2,173,009
Attributed
$4,346,017
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.3M · FY2019–24$5M$3.8M$2.5M$1.3M$0
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$4,346,017 · 3
By mechanism
R44$4,046,017 · 2
R43$300,000 · 1
Top collaborators
- Rahul Jadia4 shared
Most similar at Revbio, Inc.
Same institution · by research overlap
- Rahul Jadia$2,173,009
- Brian Hess$10,881,658
Others in their field
Other Emerging Leaders on “Canis Familiaris”
- Xinhua Li · Nano Terra, Inc.$23,898,883
- John Otridge · Leidos Biomedical Research, Inc.$8,845,576
- James N Campbell · Centrexion Therapeutics Corporation$8,662,635
- Christian Arthur Heidbreder · Indivior, Inc.$8,483,680
- Nikej Shah · Nirsum Laboratories, Inc.$7,722,108
- Judith A Kelleher-Andersson · Neuronascent, Inc.$7,074,883
Research focus
Canis FamiliarisBoneRegenerativeTissuesMineralsImplantOperative Surgical ProceduresPropertyAdhesivesBiocompatible MaterialsBone RegenerationPharmaceutical PreparationsFundingImplantationEnsureDevicesFeedbackIn VitroDental AdhesiveCanine ModelBone TransplantationDefectDental ImplantsApplications Grants
Grant awards (4)
Development of a Novel Bone Adhesive Scaffold to Accelerate Bone Regeneration and Improve Ridge Height Maintenance for the Treatment of Patients with Residual Ridge Resorption$730,212
R44 · FY2024 · DE
A Novel Opioid-Free Targeted Pain Control Method for Acute Post-Operative Localized Pain Related to Oral Surgical Procedures$2,050,357
R44 · FY2023 · DE
Development of a Novel Bone Adhesive Scaffold to Accelerate Bone Regeneration and Improve Ridge Height Maintenance for the Treatment of Patients with Residual Ridge Resorption$1,265,448
R44 · FY2023 · DE
A Novel Opioid-Free Targeted Pain Control Method for Acute Post-Operative Localized Pain Related to Oral Surgical Procedures$300,000
R43 · FY2019 · DE